BAKER BROS. ADVISORS LLC, IN ITS CAPACITY AS COLLATERAL AGENT
Patent Owner
Stats
- 13 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 27, 2009 most recent publication
Details
- 13 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 293 Total Citation Count
- Aug 23, 1991 Earliest Filing
- 13 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7608393 Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patientsDec 31, 03Oct 27, 09[C07H, C12Q, G01N]
RE39138 Monoclonal antibody specific for advanced glycosylation endproducts in biological samplesDec 16, 99Jun 20, 06[A61K]
6613519 Method of determining a risk of hyperglycemic patients of developing a cardiovascular diseaseMar 23, 01Sep 02, 03[C07H, C12Q]
6599702 Method of evaluating a risk of a subject of developing vascular complicationsOct 16, 00Jul 29, 03[C07H, C12Q, C12P, G01N]
6251608 Method of determining a potential of a hyperglycemic patients of developing vascular complicationsApr 20, 00Jun 26, 01[C07H, C12Q, C12P, G01N]
5700447 Methods and materials for the diagnosis and treatment of conditions such as strokeOct 07, 94Dec 23, 97[G01N]
5698197 Monoclonal antibody specific for advanced glycosylation endproducts in biological samplesJun 07, 95Dec 16, 97[A61K, C07K]
5683887 Immunochemical detection of in vivo advanced glycosylation endproductsJun 07, 95Nov 04, 97[G01N]
5629408 Immunochemical isolation of in vivo advanced glycosylation endproductsJun 07, 95May 13, 97[G01N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2009/0246,770 GLYCEMIC CONTROL FOR REDUCTION OF CARDIOVASCULAR DISEASE RISK IN DIABETIC PATIENTS EXPRESSING HAPTOGLOBIN 2-2AbandonedOct 31, 08Oct 01, 09[C12Q]
2009/0137,617 USE OF HAPTOGLOBIN GENOTYPING IN DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASEAbandonedNov 24, 08May 28, 09[A61K]
2009/0074,740 Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (RCT)AbandonedMay 14, 08Mar 19, 09[A61K, C12Q]
2008/0213,785 Method of predicting a benefit of antioxidant therapy for prevention or treatment of vasclar disease in hyperglycemic individualsAbandonedFeb 19, 08Sep 04, 08[C12Q]
2008/0044,399 Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotypeAbandonedMay 14, 07Feb 21, 08[A61K, C12Q, A61P]
2007/0218,462 Method of Predicting a Benefit of Antioxidant Therapy for Prevention of Cardiovascular Disease in Hiperglycemic PatientsAbandonedNov 03, 04Sep 20, 07[C12Q, G01N]
5892000 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samplesExpiredDec 29, 95Apr 06, 99[C07K]
5744318 Monoclonal antibody for the detection of advanced glycosylation endproducts in biological samplesExpiredDec 30, 94Apr 28, 98[C12Q, G01N, C07K]
5733524 Methods and materials for the diagnosis and treatment of conditions such as strokeExpiredJun 07, 95Mar 31, 98[A61K, G01N]
5733546 Immunochemical detection of in vivo advanced glycosylation endproductsExpiredJun 07, 95Mar 31, 98[A61K, C07K]
5733933 Methods and materials for the diagnosis and treatment of conditions such as strokeExpiredJun 07, 95Mar 31, 98[A61K]
5712101 Immunochemical detection of in vivo advanced glycosylation endproductsExpiredJun 07, 95Jan 27, 98[G01N]
5585344 Liver-derived receptors for advanced glycosylation endproducts and uses thereofExpiredAug 23, 91Dec 17, 96[A61K, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.